Individual and regional variations of phospho-tau species in progressive supranuclear palsy
Standard
Individual and regional variations of phospho-tau species in progressive supranuclear palsy. / Puig, Berta; Rey, María Jesus; Ferrer, Isidre; Puig Martorell, Berta.
in: ACTA NEUROPATHOL, Jahrgang 110, Nr. 3, 01.09.2005, S. 261-8.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Individual and regional variations of phospho-tau species in progressive supranuclear palsy
AU - Puig, Berta
AU - Rey, María Jesus
AU - Ferrer, Isidre
AU - Puig Martorell, Berta
PY - 2005/9/1
Y1 - 2005/9/1
N2 - The purpose of this study was to learn about possible variations in phospho-tau profiles in terms of case-to-case differences, regional modifications and diversification of tau phosphorylation sites in five PSP cases with moderate to severe frontosubcortical dysfunction. Gel electrophoresis of sarkosyl-insoluble fractions and Western blotting with five anti-tau phospho-specific antibodies directed to phosphorylation sites Thr181, Ser202, Ser214, Ser396 and Ser422 were used to study four brain regions including frontal cortex, area 8, subcortical white matter of the frontal lobe, caudate/putamen: striatum, and basis pontis: pons. Although two bands of 66 and 62 kDa were observed in almost every region in each case, the intensity of the bands depends on the anti-tau phospho-specific antibody. More importantly, bands of 72, 50/55 and 37 kDa were commonly found in PSP brains, whereas other bands of about 60, 42, 33 and 29 kDa were irregularly observed. The pattern of bands differed slightly from one case to another and from one region to another. Moreover, the phospho-tau profile differed depending on the anti-tau phospho-specific antibody used. These data suggest that several species of tau are variably phosphorylated at a given time in a given region (and probably in a given cell), and that tau aggregates are composed of several phosphorylated truncated or cleaved tau molecules, in addition to phosphorylated complete tau isoforms.
AB - The purpose of this study was to learn about possible variations in phospho-tau profiles in terms of case-to-case differences, regional modifications and diversification of tau phosphorylation sites in five PSP cases with moderate to severe frontosubcortical dysfunction. Gel electrophoresis of sarkosyl-insoluble fractions and Western blotting with five anti-tau phospho-specific antibodies directed to phosphorylation sites Thr181, Ser202, Ser214, Ser396 and Ser422 were used to study four brain regions including frontal cortex, area 8, subcortical white matter of the frontal lobe, caudate/putamen: striatum, and basis pontis: pons. Although two bands of 66 and 62 kDa were observed in almost every region in each case, the intensity of the bands depends on the anti-tau phospho-specific antibody. More importantly, bands of 72, 50/55 and 37 kDa were commonly found in PSP brains, whereas other bands of about 60, 42, 33 and 29 kDa were irregularly observed. The pattern of bands differed slightly from one case to another and from one region to another. Moreover, the phospho-tau profile differed depending on the anti-tau phospho-specific antibody used. These data suggest that several species of tau are variably phosphorylated at a given time in a given region (and probably in a given cell), and that tau aggregates are composed of several phosphorylated truncated or cleaved tau molecules, in addition to phosphorylated complete tau isoforms.
KW - Aged
KW - Amino Acid Sequence
KW - Binding Sites
KW - Blotting, Western
KW - Brain
KW - Electrophoresis, Gel, Two-Dimensional
KW - Female
KW - Humans
KW - Male
KW - Molecular Weight
KW - Neurons
KW - Peptide Fragments
KW - Phosphorylation
KW - Serine
KW - Supranuclear Palsy, Progressive
KW - Threonine
KW - tau Proteins
U2 - 10.1007/s00401-005-1046-0
DO - 10.1007/s00401-005-1046-0
M3 - SCORING: Journal article
C2 - 15973541
VL - 110
SP - 261
EP - 268
JO - ACTA NEUROPATHOL
JF - ACTA NEUROPATHOL
SN - 0001-6322
IS - 3
ER -